VIRACTA THERAPEUTICS, INC. Chart calendar Viracta Therapeutics, Inc.
d98cfdb1410195898050d31.dor-JQuVbxKDFuMxqGF9MvbNjLI5JNcgN1THrbl0dPA.BrunfWDmFk3OWdVwmBlKccGl_IcIF49kRRWYzo8BO7464bxtTcUKR7tlrg~bb03063d064c14bce0c95bd7d62e17a2
Upcoming events on Viracta Therapeutics, Inc.
Past events on Viracta Therapeutics, Inc.
| 13/04/2024 03:12 | Taiwan Society of Blood and Marrow Transplantation and The Hematology Society Congress |
| 07/03/2024 21:05 | Q4 2023 Earnings Release |
| 13/02/2024 17:00 | Oppenheimer Healthcare Life Sciences Conference |
| 29/11/2023 20:25 | Evercore ISI HealthCONx Conference |
| 28/11/2023 17:10 | Piper Sandler Healthcare Conference |
| 15/11/2023 15:20 | Stifel Healthcare Conference |
| 09/11/2023 13:30 | Q3 2023 Earnings Release |
| 04/10/2023 13:00 | Research and Development Day |
| 14/08/2023 13:00 | Q2 2023 Earnings Release |
| 07/06/2023 | Annual General Meeting |
| 07/06/2023 20:00 | Jefferies Global Healthcare Conference |
| 17/05/2023 21:05 | RBC Global Healthcare Conference |
| 08/05/2023 21:05 | Q1 2023 Earnings Release |
| 26/04/2023 17:00 | Stifel Targeted Oncology Days - Fireside Chat |
| 15/03/2023 16:00 | Oppenheimer Healthcare Conference |
| 13/03/2023 20:05 | Q4 2022 Earnings Release |
| 14/02/2023 18:00 | SVB Securities Global Biopharma Conference |
| 30/11/2022 18:50 | Evercore ISI HealthCONx Conference |
| 29/11/2022 15:30 | Piper Sandler Healthcare Conference |
| 16/11/2022 17:35 | Jefferies London Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -12,1 | -128 -125 -2.12% | -50,6 -52,4 3.5% | -50,7 -50,6 -0.27% | -59,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -115 -116 0.83% | -49,2 -52,2 5.69% | -51,1 -50,4 -1.28% | -60,1 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -115 -116 0.83% | -49,2 -53,8 8.56% | -51,1 -50,8 -0.59% | -62,4 |
|
EPS USD | Released Forecast Spread | -5,75 | -3,60 -3,63 0.83% | -1,30 -1,40 7.28% | -1,32 -1,28 -3.53% | -1,16 |
| Announcement Date | 22/12/20 | 16/03/22 | 13/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -11,3 -17,7 35.92% | -10,4 -10,8 3.3% | -10,5 -11,2 6.1% | -18,1 -11,5 -56.92% | -11,6 -13,4 13.71% | -12,2 -12,0 -1.84% | -12,5 -12,6 0.84% | -12,5 -13,1 4.68% | -13,6 -13,4 -1.01% | -13,7 | -14,5 | -15,3 | -16,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,4 -12,4 7.7% | -10,5 -11,7 9.91% | -10,6 -11,4 6.95% | -17,7 -11,5 -54.03% | -10,3 -13,3 22.34% | -12,2 -11,9 -2.72% | -12,5 -12,4 -0.84% | -12,6 -13,0 2.98% | -13,8 -13,1 -4.9% | -13,8 | -14,6 | -15,4 | -16,4 |
|
Net income Million USD | Released Forecast Spread | -11,4 -12,4 7.7% | -10,5 -12,0 12.14% | -10,6 -11,4 7.47% | -17,7 -11,6 -53.1% | -10,3 -14,9 30.57% | -12,2 -12,2 -0.16% | -12,5 -12,5 0.48% | -12,6 -13,2 4.32% | -13,8 -13,2 -4.53% | -14,1 | -14,9 | -15,8 | -17,5 |
|
EPS USD | Released Forecast Spread | -0,31 -0,33 6.06% | -0,28 -0,32 11.11% | -0,28 -0,30 6.67% | -0,47 -0,31 -54.1% | -0,27 -0,39 29.87% | -0,32 -0,31 -2.4% | -0,32 -0,29 -10.34% | -0,33 -0,31 -8.2% | -0,35 -0,31 -12.9% | -0,35 | -0,31 | -0,26 | -0,28 |
| Announcement Date | 16/03/22 | 10/05/22 | 09/08/22 | 10/11/22 | 13/03/23 | 08/05/23 | 14/08/23 | 09/11/23 | 07/03/24 | - | - | - | - |
More events
Past sector events for Viracta Therapeutics, Inc.
| 02/05/2024 13:00 | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | MODERNA, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | INTELLIA THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
